Liquidia Technologies names Dr. Mike Royal SVP, clinical development: 3 points

Liquidia Technologies, a privately held biotechnology company, named Mike Royal, MD, senior vice president, clinical development.

Advertisement

Here are three points:

1. Dr. Royal will be responsible for the company’s clinical research and development programs.  

2. Most recently, Dr. Royal was executive vice president of clinical and regulatory affairs at Sorrento Therapeutics.

3. He has also been a clinical adjunct assistant professor of anesthesiology/pain management at the University of California, San Diego and at University of Oklahoma Medical School in Oklahoma City.

More articles on anesthesia:
University of Tennessee Medical Center names Dr. Jerry Epps CMO: 4 things to know
Drs. Ladd Campbell, Bradley Stone receive ABA’s pediatric anesthesiology certification: 4 notes
Anesthesiologist Dr. Douglas Hester to showcase poetry at Vanderbilt University’s library lectures series: 3 notes

Advertisement

Next Up in Anesthesia

Advertisement

Comments are closed.